TSE:CRON

Cronos Group Inc. (CRON.TO) Stock Forecast, Price & News

C$9.66

+0.22 (+2.33 %)

(As of 11/23/2020 02:39 PM ET)

Add

Compare

Today's Range

C$9.24

Now: C$9.66▼

C$9.77

50-Day Range

C$6.63

MA: C$7.93▼

C$9.82

52-Week Range

C$5.82

Now: C$9.66▼

C$11.74

Volume868,865 shs

Average Volume1.01 million shs

Market CapitalizationC$3.44 billion

P/E Ratio33.66

Dividend YieldN/A

BetaN/A

Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.

Beat the Market (BTM) Rank^™

1.1 Analyst's Opinion

Consensus Rating
Cronos Group Inc. (CRON.TO) has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of C$8.07, Cronos Group Inc. (CRON.TO) has a forecasted downside of 16.7% from its current price of C$9.69.
Amount of Analyst Coverage
Cronos Group Inc. (CRON.TO) has only been the subject of 1 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
Cronos Group Inc. (CRON.TO) has received 59 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cronos Group Inc. (CRON.TO) has received 79 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cronos Group Inc. (CRON.TO) has received 57.25% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cronos Group Inc. (CRON.TO) and other stocks. Vote “Outperform” if you believe CRON will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cronos Group Inc. (CRON.TO) does not currently pay a dividend.
Dividend Growth
Cronos Group Inc. (CRON.TO) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Group Inc. (CRON.TO) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cronos Group Inc. (CRON.TO) is 33.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 20.77.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cronos Group Inc. (CRON.TO) is 33.76, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.13.
Price to Earnings Growth Ratio
Cronos Group Inc. (CRON.TO) has a PEG Ratio of 5.10. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Cronos Group Inc. (CRON.TO) has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.64 out of 5 stars

Industry, Sector and Symbol

Stock Exchange TSE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolTSE:CRON

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.thecronosgroup.com

Phone416-504-0004

Employees631

Debt

Debt-to-Equity Ratio0.56

Current Ratio9.75

Quick Ratio9.22

Price-To-Earnings

Trailing P/E Ratio33.66

Forward P/E RatioN/A

P/E Growth5.1

Sales & Book Value

Annual SalesC$36.98 million

Price / Sales93.04

Cash FlowC$3.72 per share

Price / Cash Flow2.60

Book ValueC$4.97 per share

Price / Book1.94

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares356,187,000

Market CapC$3.44 billion

Next Earnings DateN/A

OptionableOptionable

C$9.66

+0.22 (+2.33 %)

(As of 11/23/2020 02:39 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

Cronos Group Inc. (CRON.TO) (TSE:CRON) Frequently Asked Questions

How has Cronos Group Inc. (CRON.TO)'s stock price been impacted by Coronavirus?

Cronos Group Inc. (CRON.TO)'s stock was trading at C$7.45 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CRON shares have increased by 29.9% and is now trading at C$9.68.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Cronos Group Inc. (CRON.TO)?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group Inc. (CRON.TO) in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Cronos Group Inc. (CRON.TO).

What stocks does MarketBeat like better than Cronos Group Inc. (CRON.TO)?

Wall Street analysts have given Cronos Group Inc. (CRON.TO) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cronos Group Inc. (CRON.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for CRON?

5 brokerages have issued 1-year price objectives for Cronos Group Inc. (CRON.TO)'s stock. Their forecasts range from C$5.00 to C$11.00. On average, they expect Cronos Group Inc. (CRON.TO)'s share price to reach C$8.07 in the next year. This suggests that the stock has a possible downside of 16.6%.
View analysts' price targets for Cronos Group Inc. (CRON.TO).

Who are some of Cronos Group Inc. (CRON.TO)'s key competitors?

Some companies that are related to Cronos Group Inc. (CRON.TO) include Kodiak Sciences (KOD), Berkeley Lights (BLI), Vir Biotechnology (VIR), MorphoSys (MOR), MorphoSys (MOR), BTG (BTG), MorphoSys AG (MOR.F) (MOR), Abcam plc (ABC.L) (ABC), Genus plc (GNS.L) (GNS), Trillium Therapeutics Inc. (TRIL.TO) (TRIL), Prelude Therapeutics (PRLD), Viela Bio (VIE), Kronos Bio (KRON), NGM Biopharmaceuticals (NGM) and Nurix Therapeutics (NRIX).
View all competitors.

What other stocks do shareholders of Cronos Group Inc. (CRON.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group Inc. (CRON.TO) investors own include Aurora Cannabis Inc. (ACB.TO) (ACB), Canopy Growth (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria Inc. (APHA.TO) (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), The Walt Disney (DIS) and Intel (INTC).

Who are Cronos Group Inc. (CRON.TO)'s key executives?

Cronos Group Inc. (CRON.TO)'s management team includes the following people:

Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 33, Pay $333.57k)
Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 44, Pay $299.63k)
Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 34, Pay $190.18k)
Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 63)
Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
Mr. Eric Klein, Head of Marketing
Ms. Shannon Buggy, Sr. VP & Global Head of People
Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 34)
Dr. Todd K. Abraham, Chief Innovation Officer (Age 65)
Puneet Mathur, VP & Controller

What is Cronos Group Inc. (CRON.TO)'s stock symbol?

Cronos Group Inc. (CRON.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group Inc. (CRON.TO)?

Shares of CRON and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Cronos Group Inc. (CRON.TO)'s stock price today?

One share of CRON stock can currently be purchased for approximately C$9.68.

How big of a company is Cronos Group Inc. (CRON.TO)?

Cronos Group Inc. (CRON.TO) has a market capitalization of C$3.45 billion and generates C$36.98 million in revenue each year. Cronos Group Inc. (CRON.TO) employs 631 workers across the globe.

What is Cronos Group Inc. (CRON.TO)'s official website?

The official website for Cronos Group Inc. (CRON.TO) is www.thecronosgroup.com.

How can I contact Cronos Group Inc. (CRON.TO)?

The company can be reached via phone at 416-504-0004.

This page was last updated on 11/23/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings